HBIO (STOCKS)
Harvard Bioscience Inc
$6.670000
+0.500000 (+8.10%)
Prev close: $6.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John D. Duke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $30.27M
- Employees
- 355
- P/E (TTM)
- -2.87
- P/B (TTM)
- 3.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.14 | $-0.21 | +0.0742 | +34.64% |
|
Mar 2026 (Q1)
|
$-0.33 | $-0.63 | +0.3024 | +47.82% |
|
Dec 2025 (Q4)
|
$0.00 | $0.36 | -0.3570 | -100.00% |
|
Sep 2025 (Q3)
|
$0.00 | $0.05 | -0.0510 | -100.00% |
Financial Statements
| Revenues | $87.81M |
| Benefits Costs and Expenses | $98.35M |
| Cost Of Revenue | $36.74M |
| Costs And Expenses | $98.35M |
| Gross Profit | $51.07M |
| Nonoperating Income/Loss | -$10.30M |
| Operating Expenses | $51.31M |
| Research and Development | $9.09M |
| Other Operating Expenses | $42.22M |
| Operating Income/Loss | -$245.00K |
| Income/Loss From Continuing Operations After Tax | -$10.41M |
| Income/Loss From Continuing Operations Before Tax | -$10.54M |
| Income Tax Expense/Benefit | -$129.00K |
| Net Income/Loss | -$10.41M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.41M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.41M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.50 |
| Diluted Earnings Per Share | -$1.50 |
| Basic Average Shares | 53,626,000 |
| Diluted Average Shares | 53,626,000 |
| Assets | $76.29M |
| Current Assets | $46.46M |
| Inventory | $22.23M |
| Other Current Assets | $24.23M |
| Noncurrent Assets | $29.82M |
| Fixed Assets | $5.35M |
| Intangible Assets | $6.22M |
| Other Non-current Assets | $18.26M |
| Liabilities | $68.87M |
| Current Liabilities | $24.79M |
| Accounts Payable | $6.22M |
| Wages | $2.17M |
| Other Current Liabilities | $16.40M |
| Noncurrent Liabilities | $44.08M |
| Long-term Debt | $36.68M |
| Other Non-current Liabilities | $7.39M |
| Equity | $7.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.42M |
| Liabilities And Equity | $76.29M |
| Net Cash Flow From Operating Activities | $651.00K |
| Net Cash Flow From Operating Activities, Continuing | $651.00K |
| Net Cash Flow From Investing Activities | -$2.48M |
| Net Cash Flow From Investing Activities, Continuing | -$2.48M |
| Net Cash Flow From Financing Activities | $1.12M |
| Net Cash Flow From Financing Activities, Continuing | $1.12M |
| Net Cash Flow | -$708.00K |
| Net Cash Flow, Continuing | -$708.00K |
| Comprehensive Income/Loss | -$11.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.09M |
| Other Comprehensive Income/Loss | -$673.00K |